-+ 0.00%
-+ 0.00%
-+ 0.00%

Can Bausch + Lomb's Dry Eye Franchise Survive the FDA's Tampa Warning Letter?

Barchart·10/27/2026 16:03:48
Listen to the news
Barchart +12.50% Beat Dec 2025 $0.35 $0.32 -8.57% Miss Mar 2026 $0.06 $0.08 +33.33% Beat Jun 2026 $0.16 $0.16 unch Beat

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Bausch + Lomb reports before market open, meaning Day 0 represents the first trading session where the market reacts to results, while Day +1 captures follow-through momentum.

Earnings Date Day 0 Move Day 0 Range Day +1 Move Day +1 Range
2026-07-29 -$0.41 (-2.47%) $1.27 (7.65%) +$0.79 (+4.88%) $1.01 (6.23%)
2026-04-29 -$0.38 (-2.42%) $1.13 (7.16%) +$0.56 (+3.65%) $0.59 (3.85%)
2026-02-18 -$0.06 (-0.34%) $1.46 (8.23%) -$0.02 (-0.11%) $0.71 (3.99%)
2025-10-29 +$0.27 (+1.78%) $1.12 (7.37%) -$0.33 (-2.13%) $0.57 (3.68%)
2025-07-30 -$0.94 (-6.42%) $1.53 (10.44%) -$0.08 (-0.58%) $0.64 (4.70%)
2025-04-30 -$2.16 (-15.74%) $1.55 (11.30%) +$0.03 (+0.26%) $0.55 (4.73%)
2025-02-19 -$0.05 (-0.31%) $0.98 (5.99%) -$0.41 (-2.52%) $0.43 (2.64%)
2024-10-30 -$0.32 (-1.54%) $0.57 (2.75%) -$0.16 (-0.78%) $0.52 (2.54%)
Avg Abs Move 3.88% 7.61% 1.86% 4.05%

Historical price action reveals significant volatility around BLCO earnings releases, with an average absolute Day 0 move of 3.88% and Day 0 range of 7.61%. The Day +1 follow-through averages 1.86% with a range of 4.05%, suggesting most of the price discovery occurs in the initial session.

The most dramatic moves came in April 2025, when the stock plunged 15.74% on earnings day with an 11.30% intraday range—by far the largest reaction in the dataset. More recently, the July 2026 report saw a 2.47% decline on Day 0 but then rallied 4.88% on Day +1, indicating initial disappointment followed by reassessment. The April 2026 report showed a similar pattern with a 2.42% Day 0 decline followed by a 3.65% Day +1 recovery.

Investors should expect meaningful price movement in the 3-4% range on earnings day, with potential for larger swings if results or guidance significantly deviate from expectations. The historical pattern suggests the market tends to overreact initially, with Day +1 often providing a corrective move, particularly after negative Day 0 reactions.

Part 2.2: Options Market Expected Move

Metric Value
Expiration Date 11/20/26 (DTE 24)
Expected Move $0.89 (5.07%)
Expected Range $16.73 to $18.51
Implied Volatility 56.99%

The options market is pricing an expected move of 5.07% for the November expiration, which is moderately higher than the historical average Day 0 move of 3.88% but below the average Day 0 range of 7.61%. This suggests options traders are anticipating above-average volatility for this report, likely reflecting the regulatory and leadership uncertainties surrounding the company.

Part 3: What Analysts Are Saying

Analysts maintain a cautiously optimistic stance on Bausch + Lomb heading into earnings. The stock currently carries an average recommendation of 3.75 (between Hold and Buy), with a mean price target of $19.47—implying 10.5% upside from the current price of $17.62.

The analyst community is divided in their views: 6 analysts rate the stock a Strong Buy, 1 rates it a Moderate Buy, 8 have Hold ratings, and 1 maintains a Moderate Sell rating, with no Strong Sells. This distribution reflects the mixed sentiment around the company's near-term prospects, with nearly half the coverage universe taking a neutral stance.

Sentiment has improved over the past month, with Strong Buy ratings increasing from 5 to 6. The price target range spans from a low of $16.00 to a high of $24.00, indicating significant disagreement about the company's valuation. The high-end target suggests some analysts see substantial upside potential if BLCO can successfully navigate its regulatory challenges and maintain Miebo's commercial momentum, while the low-end target sits below the current trading price, reflecting concerns about execution risks.

The modest improvement in sentiment and the 10.5% implied upside suggest analysts believe the market has adequately priced in near-term risks, but they're waiting for clearer evidence of operational stability and regulatory resolution before becoming more constructive on the shares.

Part 4: Technical Picture

Bausch + Lomb enters earnings with strengthening technical momentum. The Barchart Technical Opinion currently shows a Buy signal at 88%, representing a significant improvement from 40% Buy just one week ago and 40% Buy one month ago. This sharp recent uptick suggests growing technical conviction heading into the report.

Timeframe Analysis:

  • Short-term (50% Buy): Moderate buy signal indicates positive near-term momentum but with less conviction than longer timeframes
  • Medium-term (100% Buy): Strong buy signal across all medium-term indicators suggests solid intermediate-term trend strength
  • Long-term (100% Buy): Maximum buy reading reflects robust longer-term uptrend momentum

Trend Characteristics: The trend is characterized by Average strength with the Strongest direction, indicating that while the magnitude of the move may be moderate, the directional conviction is at maximum levels—a supportive setup for maintaining gains through earnings volatility.

The stock is trading above all key moving averages, including the 5-day ($17.46), 10-day ($17.00), 20-day ($16.95), 50-day ($17.17), 100-day ($16.68), and 200-day ($16.63). This complete alignment above all timeframes is a bullish technical configuration.

Period Value Period Value
5-Day MA $17.46 50-Day MA $17.17
10-Day MA $17.00 100-Day MA $16.68
20-Day MA $16.95 200-Day MA $16.63

The current price of $17.62 sits just below the 50-day moving average of $17.17, suggesting the stock is testing resistance at this intermediate-term trend line. The tight clustering of the 5-day, 10-day, and 20-day moving averages in the $16.95-$17.46 range indicates recent consolidation, while the rising 100-day and 200-day averages confirm the longer-term uptrend remains intact. The technical setup is supportive heading into earnings, with the stock positioned above all major moving averages and showing improving momentum signals across multiple timeframes. However, the proximity to the 50-day average means a disappointing report could trigger a quick retreat to the $17.00-$17.17 support zone, while a positive surprise could propel shares toward the $18.50 level implied by the options expected move.

This article was generated using Barchart’s automated content technology and existing data APIs. As a result, we are able to provide readers with timely, actionable, in-depth analysis on more equities, allowing them to make more informed decisions. All information and data in this article is solely for informational purposes. For more information, please view the Barchart Disclosure Policy here. And, if you would like to report any inaccuracies, please contact news@barchart.com.